These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6083911)

  • 1. [Hypofibrinolysis and thrombophilia].
    Cepelák V; Dvorák J; Cepeláková H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):456-67. PubMed ID: 6083911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative studies on the activation of the fibrinolytic system by venous stasis and the administration of DDAVP].
    Huyke R; Vogel G; Lauten G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):480-3. PubMed ID: 6083914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of desmopressin (DDAVP) in the detection of decreased fibrinolytic capacity in persons with idiopathic venous thrombosis and myocardial infarct at a young age].
    Cepelák V; Dvorák J
    Vnitr Lek; 1985 Mar; 31(3):232-9. PubMed ID: 4036009
    [No Abstract]   [Full Text] [Related]  

  • 4. [Disorders of fibrinolysis and thrombophilic states, risk factors and possibilities of dietary effects].
    Cepelák V; Dvorák J; Vít L; Cepeláková H; Beránek V
    Vnitr Lek; 1991 Jan; 37(1):13-20. PubMed ID: 2058093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunoradiometric determination of blood/tissue plasminogen activators in thrombophilia].
    Astedt B; Fagner U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):475-9. PubMed ID: 6083913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM
    Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of fibrinolytic activity of whole blood in patients with recurrent idiopathic deep venous thrombosis.
    Harbourne T; Nicolaides AN
    J Vasc Surg; 1986 Jul; 4(1):1-4. PubMed ID: 3723686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired fibrinolytic capacity predisposes for recurrence of venous thrombosis.
    Korninger C; Lechner K; Niessner H; Gössinger H; Kundi M
    Thromb Haemost; 1984 Oct; 52(2):127-30. PubMed ID: 6523430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on C1 inactivator resistant fibrinolytic activity].
    Deguchi A; Kawamura K; Deguchi K; Tamaki S; Tanigawa M; Iwasaki E; Wada H; Murashima S; Nishikawa M; Shirakawa S
    Rinsho Byori; 1991 May; 39(5):517-22. PubMed ID: 2072575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of desmopressin acetate (DDAVP) as a test of the fibrinolytic capacity of patients--analysis of responders and non-responders.
    Brommer EJ; Barrett-Bergshoeff MM; Allen RA; Schicht I; Bertina RM; Schalekamp MA
    Thromb Haemost; 1982 Oct; 48(2):156-61. PubMed ID: 6817444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of diabetes regulation on platelet release, fibrinolysis and coagulation tests, before and after stimulation with DDAVP.
    vd Knaap JH; de Boer AC; Pannebakker MA; van Heerde W; den Ottolander GJ
    Thromb Haemost; 1985 Feb; 53(1):118-21. PubMed ID: 3922075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Late results following fibrinolysis therapy of venous thromboses].
    Breddin HK
    Internist (Berl); 1984 Feb; 25(2):102-7. PubMed ID: 6368451
    [No Abstract]   [Full Text] [Related]  

  • 13. A pilot study; desmopressin (DDAVP) in the treatment of deep venous thrombosis.
    Törnebohm E; Bratt G; Granqvist S; Lockner D; Egberg N
    Thromb Res; 1987 Mar; 45(5):635-43. PubMed ID: 3109064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasminogen deficiencies in 2 Spanish families. Response to the administration of DDAVP].
    Tabernero MD; Galende J; Tomás JF; Alberca I; Estelles A; Vicente V
    Sangre (Barc); 1990 Apr; 35(2):137-41. PubMed ID: 2363094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of the laboratory diagnosis of hypercoagulability].
    Vorlová Z; Dyr JE
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):450-5. PubMed ID: 6083910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of fibrinogen and fibrin degradation products (DFP) in the acute stage of myocardial infarction].
    Baele G; Mussche M; Vermeire P; Pannier R
    Arch Mal Coeur Vaiss; 1973 Apr; 66(4):427-9. PubMed ID: 4198846
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombophilia and hypofibrinolysis: pathophysiologies of osteonecrosis.
    Glueck CJ; Freiberg R; Tracy T; Stroop D; Wang P
    Clin Orthop Relat Res; 1997 Jan; (334):43-56. PubMed ID: 9005895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinolytic parameters in patients undergoing total hip replacement: relationship with the development of asymptomatic deep vein thrombosis and diagnostic usefulness of venous occlusion.
    Trotti R; Siragusa S; Rondanelli M; Chezzi L; Citterio A; Melzi d'Eril GV; Piovella F
    Haematologica; 1997; 82(2):178-81. PubMed ID: 9175322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential of whole blood coagulation reconstitution by desmopressin and fibrinogen under conditions of hypothermia and acidosis--an in vitro study using rotation thrombelastometry.
    Hanke AA; Dellweg C; Schöchl H; Weber CF; Jüttner B; Johanning K; Görlinger K; Rahe-Meyer N; Kienbaum P
    Scand J Clin Lab Invest; 2011 Jul; 71(4):292-8. PubMed ID: 21663556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1-Desamino-8-D-arginine vasopressin (DDAVP) in patients with congenital nephrogenic diabetes insipidus.
    Brink HS; Derkx FH; Boomsma F; Brommer EJ; Schalekamp MA
    Neth J Med; 1993 Aug; 43(1-2):5-12. PubMed ID: 8232694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.